ஜெநெடிக் நோய் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜெநெடிக் நோய். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜெநெடிக் நோய் Today - Breaking & Trending Today

When your heart's too thick to work well


Hypertrophic cardiomyopathy is a genetic heart disease that occurs in one in 500 people.
People with this condition have an abnormal arrangement of heart muscle cells, which is usually caused by gene mutations that make the heart grow abnormally thick.
This makes it more difficult for the heart to pump blood.
In some cases, those with the condition might not even be aware that they have it.
Mayo Clinic cardiologist Dr Steve Ommen, who specialises in this disease, says that shortness of breath or chest pain, especially during exercise, are common symptoms.
“It’s important to first point out that it’s completely compatible with a normal life span and a normal quality of life,” he says. ....

Steve Ommen , Mayo Clinic News Network Tribune Service , Mayo Clinic News , Tribune News , Heart Disease , Non Communicable Diseases , Genetic Disease , மயோ சிகிச்சையகம் செய்தி வலைப்பின்னல் ட்ரிப்யூன் சேவை , மயோ சிகிச்சையகம் செய்தி , ட்ரிப்யூன் செய்தி , இதயம் நோய் , அல்லாத தொடர்பு கொள்ளக்கூடியது நோய்கள் , ஜெநெடிக் நோய் ,

Worldwide Precision Medicine Industry to 2025 - Targeted Gene Therapy Presents Opportunities


Worldwide Precision Medicine Industry to 2025 - Targeted Gene Therapy Presents Opportunities
March 12, 2021 05:03 ET
| Source:
Research and Markets
Research and Markets
Dublin, IRELAND
ResearchAndMarkets.com s offering.
The Global Precision Medicine Market is estimated to be USD 53.5 Bn in 2020 and is expected to reach USD 92.2 Bn by 2025 growing at a CAGR of 11.5%.
The factors such as patient s involvement in personal healthcare, development of technologies such as sequencing technologies, increasing genetic diseases, the growing demand for targeted therapies, and integration of big data healthcare companies with pharma & biotech companies are driving the market growth. The increasing population and rising cancer cases in developing countries in the APAC region like India and China are the major factors propelling the growth of the precision medicine market. The current soaring prices of drug discov ....

United States , United Kingdom , Asia Pacific , Bristol Myers Squibb , Laura Wood , Almac Group Ltd , National Institute Of Health , Omnicell Inc , Bristol Myers Squibb Company , Precision Medicine Initiative , Pharma Biotech Companies , Astellas Pharma Inc , Pfizer Inc , Ion Semiconductor Sequencing , Healthcare It Big Data Companies , Porter Five Forces Analysis , Eli Lilly Company , Office Hours Call , Laboratory Corporation Of America Holdings , Research Methodology , Roche Holding Ag , Company Profiles , Bio Rad Laboratories Inc , E St Office Hours Call , Amgen Inc , Tool Companies ,

Genetic Testing Market revenue to cross USD 31.8 Bn by 2027: Global Market Insights Inc.


According to latest report
“Genetic Testing Market by Test Type (Predictive Testing, Carrier Testing, Prenatal and Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, Nutrigenomic Testing), Application (Cancer, Genetic Disease, Cardiovascular Disease), Regional Outlook, Price Trends, Competitive Market Share & Forecast 2027”, by Global Market Insights Inc., the
market valuation of genetic testing will cross $31.8 billion by 2027. Availability of different genetic tests across the globe for early and accurate disease diagnosis will enhance the market growth during the forecast timeline.
Direct-to-consumer genetic tests provides access to genetic information of the customers without necessarily involving any health insurance company or a healthcare provider in the process. DTC tests enable customers to identify a genetic predisposition to various diseases such as diabetes, cancer and Alzheimer’s. In addition, some DTC genetic tests are used for predicti ....

United States , United Kingdom , Asia Pacific , Global Market Insights Inc , Helix Co , Cepheid Danaher Corporation , Biocartis Group , Abbott Laboratories , Me Inc Ltd , Testing Market , Test Type , Predictive Testing , Carrier Testing , Newborn Testing , Diagnostic Testing , Pharmacogenomic Testing , Nutrigenomic Testing , Genetic Disease , Cardiovascular Disease , Regional Outlook , Price Trends , Competitive Market Share , Ambry Genetics , Konica Minolta , Blueprint Genetics , Eurofins Scientific ,